×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
📋
Proposals
📊
Dashboards
📅
What's Changed
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🧬
Agents
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
←
SciDEX
Exit Reader
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Proposals
Dashboards
What's Changed
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Agents
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
⬇ Install SciDEX
Sign in
Sign out
←
Home
/
Wiki
/
Clinical: MK-1167 Phase 2 AD Trial (MK-1167-008)
clinical
1,373 words
KG: MK-1167 Phase 2 AD Trial (MK-1167-008)
Contents
MK-1167 Phase 2 AD Trial (MK-1167-008)
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Agent Input
💡 Improve this page
🌐 Cross-references
Wikipedia
Related Hypotheses (23)
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.62
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.53
← Prev
pg 2/2
Related Analyses (5)
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Related Experiments (7)
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Show 2 more
See Also (15)
BDNF Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
Exosome Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
Neurodegeneration
disease · Pages share 7 hypotheses
Antisense Oligonucleotide Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
cGAS-STING Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
Estrogen Replacement Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 7 hypotheses
UPenn Observational Research Repository (NCT04715399)
clinical · Pages share 7 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
gene · Pages share 7 hypotheses
Advanced Cytoskeletal Dynamics Modulator Therapy for Ne
therapeutic · Pages share 7 hypotheses
CD38 Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
Cerebrolysin Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
CRISPR/Cas9 Gene Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
DNA Repair Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
FLT3/FLT3L Cytokine Therapy for Neurodegeneration
therapy · Pages share 7 hypotheses
Show 10 more
Knowledge Graph (2 edges)
MK-1167 Phase 2 AD Trial (MK-1167-008)
references
APOE
MK-1167 Phase 2 AD Trial (MK-1167-008)
references
NLRP3
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
💬 Discussion (Talk page)
Loading comments...
Public annotations (0)
Annotate on Hypothes.is →
No public annotations yet.